Abi Millar

All articles by Abi Millar

1. What does ‘ageing’ mean when it comes to drug development?

   One of the great triumphs of modern medicine is the fact that people are living longer. As of 2020, people…
   Read More…

   15 Jan
2. The rise of fake medicines in Africa

   Counterfeit drugs are a deadly, and growing, problem. According to the World Health Organization, as many as one in ten…
   Read More…

   3 Jan
3. Q&A: Gavi alliance talks immunising 300 million people

   Since Gavi, the Vaccine Alliance, was launched in 2000, it has played a major role in immunisation efforts across the…
   Read More…

   5 Dec
4. Recurrent miscarriage: could this devastating condition have a simple cure?

   For those who’ve experienced recurrent miscarriages, the devastation can be immense. While around one in five pregnancies end in miscarriage…
   Read More…

   3 Dec
5. The problem of manipulated data

   In August, Novartis came under fire for submitting manipulated data in an application to the FDA. The problem lay with…
   Read More…

   2 Dec
6. A safer ride: the latest innovation in targeted cancer treatment

   Antibody-drug conjugates (ADCs) hold the potential to change the nature of cancer treatment. Unlike classic chemotherapy – in which a…
   Read More…

   28 Nov
7. Is growth factor protein the future of Parkinson’s treatment?

   In February 2019, the pioneering GDNF clinical trials programme finally published its full results. A major, multimillion-pound project, which ran…
   Read More…

   31 Oct
8. Proteomics and the promise of ‘enriching’ clinical trials

   Proteomics – the study of the proteome – is widely used within drug discovery. A portmanteau of ‘protein genome’, the…
   Read More…

   29 Oct
9. Q&A: an eye on innovation with SparingVision

   Retinitis pigmentosa (RP), a genetic disorder of the eyes, is one of the leading causes of blindness. Thought to affect…
   Read More…

   22 Oct
10. Why is pharma so bad at sharing clinical trial data?

    Over the last few decades, pharma companies have been under ever-mounting pressure to report their clinical trial data. Beginning in…
    Read More…

    21 Oct